MKNK2 as A Prognosis-Related Biomarker for Gastric Cancer
Authors: 
Pei Kuang, Jiayu Zhang, Fujian Wan, Yingjie Zhang, Wenhua Zhang, Xiaoyu ZhangAuthors Info & Claims
Pages 61 - 68
Abstract
Gastric cancer is a deadly disease with low survival rates around the world. Even though specific drugs based on molecular biology studies of gastric cancer and improvements in how gastric cancer is treated have been made, the survival rate for people with gastric cancer has not changed enough. In this study, MKNK2 was looked at and reviewed using a public online database. It was found that gastric cancer has low levels of MKNK2. When MKNK2 was highly expressed, the prognosis for people with gastric cancer was better. Also, MKNK2 may have something to do with how the immune system gets into gastric cancer. This study shows that MKNK2 could be used to treat gastric cancer, and it lays the groundwork for more research into how gastric cancer is treated at the genetic level.
References
[1]
QIN M, LIANG Z, QIN H, Novel Prognostic Biomarkers in Gastric Cancer: CGB5, MKNK2, and PAPPA2 [J]. Frontiers in oncology, 2021, 11: 683582.
[2]
JOSHI S S, BADGWELL B D. Current treatment and recent progress in gastric cancer [J]. CA Cancer J Clin, 2021, 71(3): 264-79.
[3]
SEXTON R E, AL HALLAK M N, DIAB M, Gastric cancer: a comprehensive review of current and future treatment strategies [J]. Cancer Metastasis Rev, 2020, 39(4): 1179-203.
[4]
LEE S, RAUCH J, KOLCH W. Targeting MAPK Signaling in Cancer: Mechanisms of Drug Resistance and Sensitivity [J]. Int J Mol Sci, 2020, 21(3).
[5]
GUO Y J, PAN W W, LIU S B, ERK/MAPK signalling pathway and tumorigenesis [J]. Exp Ther Med, 2020, 19(3): 1997-2007.
[6]
WANG J, DA C, SU Y, MKNK2 enhances chemoresistance of ovarian cancer by suppressing autophagy via miR-125b [J]. Biochem Biophys Res Commun, 2021, 556: 31-8.
[7]
LIU H, GONG Z, LI K, SRPK1/2 and PP1alpha exert opposite functions by modulating SRSF1-guided MKNK2 alternative splicing in colon adenocarcinoma [J]. J Exp Clin Cancer Res, 2021, 40(1): 75.
[8]
ZHAO Z, LIU H, ZHOU X, Necroptosis-Related lncRNAs: Predicting Prognosis and the Distinction between the Cold and Hot Tumors in Gastric Cancer [J]. J Oncol, 2021, 2021: 6718443.
[9]
XIANG S, LI J, SHEN J, Identification of Prognostic Genes in the Tumor Microenvironment of Hepatocellular Carcinoma [J]. Front Immunol, 2021, 12: 653836.
[10]
XU W X, ZHANG J, HUA Y T, An Integrative Pan-Cancer Analysis Revealing LCN2 as an Oncogenic Immune Protein in Tumor Microenvironment [J]. Frontiers in oncology, 2020, 10: 605097.
[11]
LI T, FU J, ZENG Z, TIMER2.0 for analysis of tumor-infiltrating immune cells [J]. Nucleic Acids Res, 2020, 48(W1): W509-W14.
[12]
SZKLARCZYK D, GABLE A L, NASTOU K C, The STRING database in 2021: customizable protein-protein networks, and functional characterization of user-uploaded gene/measurement sets [J]. Nucleic Acids Res, 2021, 49(D1): D605-D12.
[13]
LI M, QI L, LI Y, Association of Pericardiac Adipose Tissue With Coronary Artery Disease [J]. Front Endocrinol (Lausanne), 2021, 12: 724859.
[14]
ZHANG Y F, HUANG Y, NI Y H, Systematic elucidation of the mechanism of geraniol via network pharmacology [J]. Drug Des Devel Ther, 2019, 13: 1069-75.
[15]
ZHANG J, WANG H, YUAN C, ITGAL as a Prognostic Biomarker Correlated With Immune Infiltrates in Gastric Cancer [J]. Front Cell Dev Biol, 2022, 10: 808212.
[16]
PAN J H, ZHOU H, COOPER L, LAYN Is a Prognostic Biomarker and Correlated With Immune Infiltrates in Gastric and Colon Cancers [J]. Front Immunol, 2019, 10: 6.
[17]
REN N, LIANG B, LI Y. Identification of prognosis-related genes in the tumor microenvironment of stomach adenocarcinoma by TCGA and GEO datasets [J]. Biosci Rep, 2020, 40(10).
[18]
CHEN G, LUO D, ZHONG N, GPC2 Is a Potential Diagnostic, Immunological, and Prognostic Biomarker in Pan-Cancer [J]. Front Immunol, 2022, 13: 857308.
[19]
ZHAO R, PENG C, SONG C, BICC1 as a novel prognostic biomarker in gastric cancer correlating with immune infiltrates [J]. Int Immunopharmacol, 2020, 87: 106828.
[20]
LI D, ZHAO W, ZHANG X, NEFM DNA methylation correlates with immune infiltration and survival in breast cancer [J]. Clin Epigenetics, 2021, 13(1): 112.
[21]
CHEN X, LI X, HU X, LUM Expression and Its Prognostic Significance in Gastric Cancer [J]. Frontiers in oncology, 2020, 10: 605.
[22]
WALDUM H, FOSSMARK R. Gastritis, Gastric Polyps and Gastric Cancer [J]. Int J Mol Sci, 2021, 22(12).
[23]
CHEN S, LI Y, ZHU Y, SERPINE1 Overexpression Promotes Malignant Progression and Poor Prognosis of Gastric Cancer [J]. J Oncol, 2022, 2022: 2647825.
[24]
SZKLARCZYK D, GABLE A L, LYON D, STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets [J]. Nucleic Acids Res, 2019, 47(D1): D607-D13.
[25]
LIU Y, XIANG J, PENG G, Omics- and Pharmacogenomic Evidence for the Prognostic, Regulatory, and Immune-Related Roles of PBK in a Pan-Cancer Cohort [J]. Front Mol Biosci, 2021, 8: 785370.
[26]
DENG J L, XU Y H, WANG G. Identification of Potential Crucial Genes and Key Pathways in Breast Cancer Using Bioinformatic Analysis [J]. Front Genet, 2019, 10: 695.
[27]
THRIFT A P, WENKER T N, EL-SERAG H B. Global burden of gastric cancer: epidemiological trends, risk factors, screening and prevention [J]. Nat Rev Clin Oncol, 2023.
[28]
JI J, CHEN J, WANG A, KK-LC-1 may be an effective prognostic biomarker for gastric cancer [J]. BMC Cancer, 2021, 21(1): 267.
[29]
ZHOU Y, CHEN Y, SHI Y, FAM117B promotes gastric cancer growth and drug resistance by targeting the KEAP1/NRF2 signaling pathway [J]. J Clin Invest, 2023, 133(3).
[30]
HUANG B, GUO S, ZHANG Y, MiR-223-3p alleviates trigeminal neuropathic pain in the male mouse by targeting MKNK2 and MAPK/ERK signaling [J]. Brain Behav, 2022, 12(7): e2634.
[31]
LIU B, SUN Y, TANG M, The miR-361-3p increases enzalutamide (Enz) sensitivity via targeting the ARv7 and MKNK2 to better suppress the Enz-resistant prostate cancer [J]. Cell Death Dis, 2020, 11(9): 807.
[32]
LORDICK F, CARNEIRO F, CASCINU S, Gastric cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up [J]. Ann Oncol, 2022, 33(10): 1005-20.
[33]
HUANG X Y, LIU J J, LIU X, Bioinformatics analysis of the prognosis and biological significance of VCAN in gastric cancer [J]. Immun Inflamm Dis, 2021, 9(2): 547-59.
Index Terms
- MKNK2 as A Prognosis-Related Biomarker for Gastric Cancer
Recommendations
A new strategy to identify ADAM12 and PDGFRB as a novel prognostic biomarker for matrine regulates gastric cancer via high throughput chip mining and computational verification
Abstract BackgroundGastric cancer is a life-threatening disease that poses a serious risk to human health. Although there are numerous molecular targets for gastric cancer in clinical practice, they often exhibit low specificity and sensitivity. ...
Highlights- This study investigate the key genes and mechanism of matrine in interfering with gastric cancer cells using ceRNA chip and bioinformatics methods.
- Two ceRNA regulatory axes related to gastric cancer prognosis were constructed: lncRNA ...
DERL3 functions as a tumor suppressor in gastric cancer
Graphical abstractDisplay Omitted
Highlights- A comprehensive analysis of STAD pathogenesis was conducted.
- High expression of ...
Abstract BackgroundGastric cancer is a common malignant tumor in the clinic with a high mortality rate, ranking the first among malignant tumors of the digestive system. Early gastric cancer exhibits no specific clinical symptoms ...
Genomic instability-related twelve-microRNA signatures for predicting the prognosis of gastric cancer
AbstractGastric cancer (GC) ranks fifth among all malignant tumors globally, especially in East Asia, and has attracted extensive attention and research. MicroRNA (miRNA) modulation during genomic instability (GI) may be associated with the development ...
Highlights- microRNA regulation relates to cancer development and migration.
- A genomic instability-related 12-microRNA signature could predict GC prognosis.
- miR-100-5p and miR-145-3p may promote GC cell growth, invasion, and migration.
Comments
Please enable JavaScript to view thecomments powered by Disqus.Information & Contributors
Information
Published In
May 2023
313 pages
ISBN:9798400700385
DOI:10.1145/3608164
Copyright © 2023 ACM.
Permission to make digital or hard copies of all or part of this work for personal or classroom use is granted without fee provided that copies are not made or distributed for profit or commercial advantage and that copies bear this notice and the full citation on the first page. Copyrights for components of this work owned by others than the author(s) must be honored. Abstracting with credit is permitted. To copy otherwise, or republish, to post on servers or to redistribute to lists, requires prior specific permission and/or a fee. Request permissions from [email protected].
Publisher
Association for Computing Machinery
New York, NY, United States
Publication History
Published: 07 November 2023
Check for updates
Author Tags
Qualifiers
- Research-article
- Research
- Refereed limited
Conference
ICBBT 2023
ICBBT 2023: 2023 15th International Conference on Bioinformatics and Biomedical Technology
May 26 - 28, 2023
Xi'an, China
Contributors
Other Metrics
Bibliometrics & Citations
Bibliometrics
Article Metrics
- 0Total Citations
- 16Total Downloads
- Downloads (Last 12 months)16
- Downloads (Last 6 weeks)0
Reflects downloads up to 09 Nov 2024
Other Metrics
Citations
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Sign inFull Access
View options
View or Download as a PDF file.
PDFeReader
View online with eReader.
eReaderHTML Format
View this article in HTML Format.
HTML Format